Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways

Table 4

Comparison of adverse cardiac events of both groups .

Grouping		Acute myocardial infarction	Intractable myocardial ischemia	Cardiogenic shock	Coronary blood flow reconstruction	Cardiac death	Incidence rate
Intervention group	56	1 (1.78)	1 (1.78)	0 (0.00)	1 (1.78)	0 (0.00)	5.36 (3/56)
Control group	55	4 (7.27)	2 (3.64)	1 (1.82)	2 (3.64)	1 (1.82)	18.18 (10/55)
							4.414
							0.036